A double-blind, placebo-controlled, 4-arm, Phase 2B study to asses the efficacy and safety of a 14-Day dosing regimen of 3 doses of ATB-346 versus Placebo, orally administered once daily to male and female patients diagnosed with Osteoarthritis of the Knee.


Register Today!

Trial Information

Start DateDecember 2019
End DateJan/Feb 2020
Trial Duration2 Months
Number of Visits6
Lead CRCMarija Bernstein
StatusOngoing

For additional information on this trial contact:

Phone705-566-0005